Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking.

Pillman KA, Phillips CA, Roslan S, Toubia J, Dredge BK, Bert AG, Lumb R, Neumann DP, Li X, Conn SJ, Liu D, Bracken CP, Lawrence DM, Stylianou N, Schreiber AW, Tilley WD, Hollier BG, Khew-Goodall Y, Selth LA, Goodall GJ, Gregory PA.

EMBO J. 2018 Jul 2;37(13). pii: e99016. doi: 10.15252/embj.201899016. Epub 2018 Jun 5.

2.

LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.

Boulding T, McCuaig RD, Tan A, Hardy K, Wu F, Dunn J, Kalimutho M, Sutton CR, Forwood JK, Bert AG, Goodall GJ, Malik L, Yip D, Dahlstrom JE, Zafar A, Khanna KK, Rao S.

Sci Rep. 2018 Jan 8;8(1):73. doi: 10.1038/s41598-017-17913-x.

3.

The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking.

Belle L, Ali N, Lonic A, Li X, Paltridge JL, Roslan S, Herrmann D, Conway JR, Gehling FK, Bert AG, Crocker LA, Tsykin A, Farshid G, Goodall GJ, Timpson P, Daly RJ, Khew-Goodall Y.

Sci Signal. 2015 Feb 17;8(364):ra18. doi: 10.1126/scisignal.2005547.

PMID:
25690013
4.

Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion.

Bracken CP, Li X, Wright JA, Lawrence DM, Pillman KA, Salmanidis M, Anderson MA, Dredge BK, Gregory PA, Tsykin A, Neilsen C, Thomson DW, Bert AG, Leerberg JM, Yap AS, Jensen KB, Khew-Goodall Y, Goodall GJ.

EMBO J. 2014 Sep 17;33(18):2040-56. doi: 10.15252/embj.201488641. Epub 2014 Jul 28.

5.

Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition.

Kolesnikoff N, Attema JL, Roslan S, Bert AG, Schwarz QP, Gregory PA, Goodall GJ.

J Biol Chem. 2014 Apr 18;289(16):11194-205. doi: 10.1074/jbc.M113.529172. Epub 2014 Mar 13.

6.

Identification of an enhancer that increases miR-200b~200a~429 gene expression in breast cancer cells.

Attema JL, Bert AG, Lim YY, Kolesnikoff N, Lawrence DM, Pillman KA, Smith E, Drew PA, Khew-Goodall Y, Shannon F, Goodall GJ.

PLoS One. 2013 Sep 25;8(9):e75517. doi: 10.1371/journal.pone.0075517. eCollection 2013.

7.

MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.

Li X, Roslan S, Johnstone CN, Wright JA, Bracken CP, Anderson M, Bert AG, Selth LA, Anderson RL, Goodall GJ, Gregory PA, Khew-Goodall Y.

Oncogene. 2014 Jul 31;33(31):4077-88. doi: 10.1038/onc.2013.370. Epub 2013 Sep 16.

PMID:
24037528
8.

Hoxb8 regulates expression of microRNAs to control cell death and differentiation.

Salmanidis M, Brumatti G, Narayan N, Green BD, van den Bergen JA, Sandow JJ, Bert AG, Silke N, Sladic R, Puthalakath H, Rohrbeck L, Okamoto T, Bouillet P, Herold MJ, Goodall GJ, Jabbour AM, Ekert PG.

Cell Death Differ. 2013 Oct;20(10):1370-80. doi: 10.1038/cdd.2013.92. Epub 2013 Jul 19.

9.

Circulating microRNAs predict biochemical recurrence in prostate cancer patients.

Selth LA, Townley SL, Bert AG, Stricker PD, Sutherland PD, Horvath LG, Goodall GJ, Butler LM, Tilley WD.

Br J Cancer. 2013 Aug 6;109(3):641-50. doi: 10.1038/bjc.2013.369. Epub 2013 Jul 11.

10.

Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.

Lim YY, Wright JA, Attema JL, Gregory PA, Bert AG, Smith E, Thomas D, Lopez AF, Drew PA, Khew-Goodall Y, Goodall GJ.

J Cell Sci. 2013 May 15;126(Pt 10):2256-66. doi: 10.1242/jcs.122275. Epub 2013 Mar 22.

11.
12.

The inducible tissue-specific expression of the human IL-3/GM-CSF locus is controlled by a complex array of developmentally regulated enhancers.

Baxter EW, Mirabella F, Bowers SR, James SR, Bonavita AM, Bertrand E, Strogantsev R, Hawwari A, Bert AG, Gonzalez de Arce A, West AG, Bonifer C, Cockerill PN.

J Immunol. 2012 Nov 1;189(9):4459-69. doi: 10.4049/jimmunol.1201915. Epub 2012 Sep 28.

13.

An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.

Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim YY, Lindeman GJ, Shannon MF, Drew PA, Khew-Goodall Y, Goodall GJ.

Mol Biol Cell. 2011 May 15;22(10):1686-98. doi: 10.1091/mbc.E11-02-0103. Epub 2011 Mar 16.

14.

Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1.

Oakford PC, James SR, Qadi A, West AC, Ray SN, Bert AG, Cockerill PN, Holloway AF.

Leuk Res. 2010 Sep;34(9):1203-13. doi: 10.1016/j.leukres.2010.03.029. Epub 2010 May 1.

PMID:
20439113
15.

Transcription-dependent silencing of inducible convergent transgenes in transgenic mice.

Calero-Nieto FJ, Bert AG, Cockerill PN.

Epigenetics Chromatin. 2010 Jan 19;3(1):3. doi: 10.1186/1756-8935-3-3.

16.

MicroRNAs as regulators of epithelial-mesenchymal transition.

Gregory PA, Bracken CP, Bert AG, Goodall GJ.

Cell Cycle. 2008 Oct;7(20):3112-8. Epub 2008 Oct 25. Review.

PMID:
18927505
17.

The microRNA-200 family regulates epithelial to mesenchymal transition.

Paterson EL, Kolesnikoff N, Gregory PA, Bert AG, Khew-Goodall Y, Goodall GJ.

ScientificWorldJournal. 2008 Sep 21;8:901-4. doi: 10.1100/tsw.2008.115.

18.

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ.

Cancer Res. 2008 Oct 1;68(19):7846-54. doi: 10.1158/0008-5472.CAN-08-1942.

19.

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.

Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ.

Nat Cell Biol. 2008 May;10(5):593-601. doi: 10.1038/ncb1722. Epub 2008 Mar 30.

PMID:
18376396
21.

Assessing IRES activity in the HIF-1alpha and other cellular 5' UTRs.

Bert AG, Grépin R, Vadas MA, Goodall GJ.

RNA. 2006 Jun;12(6):1074-83. Epub 2006 Apr 6.

22.

Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter.

Coles LS, Lambrusco L, Burrows J, Hunter J, Diamond P, Bert AG, Vadas MA, Goodall GJ.

FEBS Lett. 2005 Oct 10;579(24):5372-8. Epub 2005 Sep 20.

24.
25.

Reconstitution of T cell-specific transcription directed by composite NFAT/Oct elements.

Bert AG, Burrows J, Hawwari A, Vadas MA, Cockerill PN.

J Immunol. 2000 Nov 15;165(10):5646-55.

26.

Generation of an improved luciferase reporter gene plasmid that employs a novel mechanism for high-copy replication.

Bert AG, Burrows J, Osborne CS, Cockerill PN.

Plasmid. 2000 Sep;44(2):173-82.

PMID:
10964627
27.

The human granulocyte-macrophage colony-stimulating factor gene is autonomously regulated in vivo by an inducible tissue-specific enhancer.

Cockerill PN, Bert AG, Roberts D, Vadas MA.

Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15097-102.

28.

Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway.

Xia P, Gamble JR, Rye KA, Wang L, Hii CS, Cockerill P, Khew-Goodall Y, Bert AG, Barter PJ, Vadas MA.

Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14196-201.

29.
30.

Regulation of GM-CSF gene transcription by core-binding factor.

Cockerill PN, Osborne CS, Bert AG, Grotto RJ.

Cell Growth Differ. 1996 Jul;7(7):917-22.

31.
32.

Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c.

Cockerill PN, Bert AG, Jenkins F, Ryan GR, Shannon MF, Vadas MA.

Mol Cell Biol. 1995 Apr;15(4):2071-9.

33.

The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer.

Cockerill PN, Shannon MF, Bert AG, Ryan GR, Vadas MA.

Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2466-70.

34.

Supplemental Content

Support Center